HC Deb 15 January 1998 vol 304 cc285-6W
Mr. Llwyd

To ask the Secretary of State for Health what research his Department is currently supporting into the possible side effects of the use of Lariam; and if he will make a statement. [18270]

Ms Jowell

None. The recommendations of the Malaria Advisory Committee on the prevention of malaria for United Kingdom travellers were published by the Public Health Laboratory Service in the Communicable Disease Report on 19 September. Copies are available in the Library.

As for all marketed medicines, the available research into the side effects of melfloquine was assessed at the time of granting the Marketing Authorisation and continues to be evaluated by the Medicines Control Agency whenever new information emerges. Recognised side effects for mefloquine are included in the authorised product information and the British National Formulary. The current produce information for doctors and patients for Lariam is consistent with the newly published guidelines and the product information advises doctors to refer to these, for current advice on geographical resistance patterns and appropriate chemoprophylaxis.

Back to
Forward to